Adam Robertson, Guro Kristoffersen, Sandra Cantilena, Claudia Katharina Petritsch, Ella Sorani. "GLIX1: A first-in-class oral molecule targeting the DNA damage response by restoring TET2 activity.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.e14072